New scan could spot breast cancer types without a needle
NCT ID NCT07292571
First seen Jan 06, 2026 · Last updated May 10, 2026 · Updated 16 times
Summary
This study tests a special radioactive tracer that lights up different levels of HER2 protein in breast cancer during a SPECT/CT scan. About 50 adults with known HER2 status will get one scan to see if the tracer can tell HER2-positive from HER2-negative tumors. The goal is to improve diagnosis, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk, Russia
Conditions
Explore the condition pages connected to this study.